SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Extended search

AMNE:(MEDICIN OCH HÄLSOVETENSKAP Klinisk medicin Reumatologi och inflammation)
 

Search: AMNE:(MEDICIN OCH HÄLSOVETENSKAP Klinisk medicin Reumatologi och inflammation) > Bengtsson Anders A > Örebro University > Type I IFN system a...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Type I IFN system activation in newborns exposed to Ro/SSA and La/SSB autoantibodies in utero

Hedlund, Malin (author)
Karolinska Institutet,Karolinska Institute,Karolinska University Hospital
Thorlacius, Gudny Ella (author)
Karolinska Institutet,Karolinska Institute,Karolinska University Hospital
Ivanchenko, Margarita (author)
Karolinska Institutet,Karolinska Institute,Karolinska University Hospital
show more...
Ottosson, Vijole (author)
Karolinska Institutet,Karolinska Institute,Karolinska University Hospital
Kyriakidis, Nikolaos (author)
Karolinska Institute,Universidad de Las Américas de Ecuador,Karolinska University Hospital
Lagnefeldt, Linda (author)
Karolinska Institute,Karolinska University Hospital
Tingström, Joanna (author)
Karolinska Institutet,Karolinska Institute,Karolinska University Hospital
Sirsjö, Allan, 1959- (author)
Örebro University,Örebro universitet,Institutionen för medicinska vetenskaper,Cardiovascular Research Centre
Bengtsson, Anders A. (author)
Lund University,Lunds universitet,Lund SLE Research Group,Forskargrupper vid Lunds universitet,Lund University Research Groups
Aronsson, Emma (author)
Karolinska Institutet,Karolinska Institute,Karolinska University Hospital
Gemzell-Danielsson, Kristina (author)
Karolinska Institutet,Karolinska Institute,Karolinska University Hospital
Rönnblom, Lars (author)
Uppsala University,Uppsala universitet,Reumatologi,Science for Life Laboratory, SciLifeLab,Rheumatology, Department of Medical Sciences, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
Bergman, Gunnar (author)
Karolinska Institutet,Karolinska Institute,Karolinska University Hospital
Espinosa, Alexander (author)
Karolinska Institutet,Karolinska Institute,Karolinska University Hospital
Sonesson, Sven-Erik (author)
Karolinska Institute,Karolinska University Hospital
Eloranta, Maija-Leena (author)
Uppsala University,Uppsala universitet,Reumatologi,Science for Life Laboratory, SciLifeLab,Rheumatology, Department of Medical Sciences, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
Wahren-Herlenius, Marie (author)
Karolinska Institutet,Karolinska Institute,Karolinska University Hospital
show less...
 (creator_code:org_t)
2020-01-07
2020
English.
In: RMD Open. - : BMJ. - 2056-5933. ; 6:1
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • OBJECTIVE: In utero exposure of the fetus to Ro/La autoantibodies may lead to congenital heart block (CHB). In the mother, these autoantibodies are associated with activation of the type I interferon (IFN)-system. As maternal autoantibodies are transferred to the fetus during pregnancy, we investigated whether the type I IFN-system is activated also in newborns of anti-Ro/La positive mothers, and whether fetal IFN activation is affected by maternal immunomodulatory treatment.METHODS: Blood drawn at birth from anti-Ro/La positive mothers, their newborns and healthy control pairs was separated into plasma and peripheral blood mononuclear cells (PBMC). PBMC were analysed directly or cultured. mRNA expression was analysed by microarrays, cell surface markers by flow cytometry, and IFNα levels by immunoassays.RESULTS: We observed increased expression of IFN-regulated genes and elevated plasma IFNα levels not only in anti-Ro/La positive women, but also in their newborns. CD14+ monocytes of both anti-Ro/La positive mothers and their neonates showed increased expression of Sialic acid-binding Ig-like lectin-1, indicating cellular activation. Notably, the IFN score of neonates born to mothers receiving immunomodulatory treatment was similar to that of controls, despite persistent IFN activation in the mothers. In both maternal and neonatal PBMC, IFNα production was induced when cells were cultured with anti-Ro/La positive plasma.CONCLUSIONS: Ro/La autoantibody-exposed neonates at risk of CHB have signs of an activated immune system with an IFN signature. This study further demonstrates that neonatal cells can produce IFNα when exposed to autoantibody-containing plasma, and that maternal immunomodulatory treatment may diminish the expression of IFN-regulated genes in the fetus.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Reumatologi och inflammation (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Rheumatology and Autoimmunity (hsv//eng)

Keyword

Sjøgren's syndrome
autoantibodies
autoimmune diseases
Medicinsk vetenskap
Medical Science
autoantibodies
autoimmune diseases
Sjøgren's syndrome

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

  • RMD Open (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view